524322 KABRADG

Kabra Drugs Share Price

₹20.83 +0.99 (4.99%)

Stock touched 52W high

08 Jul, 2025 19:35

SIP TrendupStart SIP in KABRADG

Start SIP

Performance

  • Low
  • ₹20
  • High
  • ₹21
  • 52 Week Low
  • ₹8
  • 52 Week High
  • ₹21
  • Open Price₹21
  • Previous Close₹20
  • Volume274,561

Investment Returns

  • Over 1 Month + 79.11%
  • Over 3 Month + 88%
  • Over 6 Month + 107.06%
  • Over 1 Year + 163.34%
SIP Lightning

Smart Investing Starts Here Start SIP with Kabra Drugs for Steady Growth!

Invest Now

Kabra Drugs Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -45.5
  • PEG Ratio
  • 1
  • Market Cap Cr
  • 49
  • P/B Ratio
  • 2
  • Average True Range
  • 0.51
  • EPS
  • -
  • Dividend Yield
  • 0
  • MACD Signal
  • 1.66
  • RSI
  • 99.96
  • MFI
  • 100

Kabra Drugs Financials

Kabra Drugs Technicals

EMA & SMA

Current Price
₹20.83
+ 0.99 (4.99%)
pointer
  • stock-down_img
  • Bearish Moving Average 0
  • stock-up_img
  • Bullish Moving Average 16
  • 20 Day
  • ₹15.30
  • 50 Day
  • ₹12.42
  • 100 Day
  • ₹10.09
  • 200 Day
  • ₹7.91

Resistance and Support

20.63 Pivot Speed
  • R3 21.62
  • R2 21.22
  • R1 21.03
  • S1 20.44
  • S2 20.04
  • S3 19.85

What's your outlook on Kabra Drugs?

You can only vote once!

Kabra Drugs Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-06-18 Others Inter-alia, to consider 1. New acquisition. 2. New drug license for a Chennai office. 3. Diversification by creating new subsidiary. 4. Other business matters.
2025-05-30 Audited Results
2025-02-14 Quarterly Results
2024-11-14 Quarterly Results
2024-11-04 Others

Kabra Drugs F&O

Kabra Drugs Shareholding Pattern

0%
95.94%
4.06%

About Kabra Drugs

  • NSE Symbol
  • KABRADG
  • BSE Symbol
  • 524322
  • Managing Director
  • Mr. N Aravind
  • ISIN
  • INE323K01017

Similar Stocks to Kabra Drugs

Kabra Drugs FAQs

Kabra Drugs share price is ₹20 As on 08 July, 2025 | 19:21

The Market Cap of Kabra Drugs is ₹49.4 Cr As on 08 July, 2025 | 19:21

The P/E ratio of Kabra Drugs is -45.5 As on 08 July, 2025 | 19:21

The PB ratio of Kabra Drugs is 2 As on 08 July, 2025 | 19:21

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23